Skip to main content
. 2020 Oct 15;13:10475–10487. doi: 10.2147/OTT.S253758

Figure 3.

Figure 3

CDC20 expression was elevated in DLBCL, and overexpression of CDC20 could be an unfavorable prognostic factor. (A) Venn diagram showing 74 upregulated genes in GSE32018 and GSE56315 datasets. CDC20 was up-regulated in these two GEO datasets. (B and C) Scatterplot indicated that CDC20 mRNA level was elevated in both GSE32018 and GSE56315 datasets. (D) TCGA DLBCL confirmed that CDC20 was overexpressed in DLBCL. (E and F) RT-qPCR and Western blot assays detected CDC20 expression in DLBCL cells and PBMCs. (G) IHC of CDC20 expression in one normal and two representative cases of 97 DLBCL tissues (× 200, scale bar, 50μm). (H) Kaplan–Meier OS analysis of 97 DLBCL patients with different CDC20 protein expression levels. (I) Association between CDC20 expression level and OS in DLBCL based on GSE31312 (n=470). Kaplan-Meier survival curves were generated by using R2 (http://r2.amc.nl). *P < 0.05, **P < 0.01, ***P < 0.001.

Abbreviations: DLBCL, diffuse large B-cell lymphoma; TCGA, The Cancer Genome Atlas; num, number; T, tumor; N, normal; PBMCs, peripheral blood mononuclear cells; IHC, immunohistochemistry; OS, overall survival.